Literature DB >> 20490608

Development of a method for effective amplification of human adenovirus 40.

Satoshi Yamasaki1, Yoshiaki Miura, Eric Brown, Julia Davydova, Masato Yamamoto.   

Abstract

Human adenovirus 40 (Ad40) is an interesting candidate for vector construction because of its tropism for the gastrointestinal tract. Although effective preparation of the vector is necessary for its in vivo application, amplification of Ad40 has been very difficult. Ad40 E1 deletion mutants were detected by PCR in the viral DNA from Ad40 Dugan amplified by Ad5 E1-expressing human embryonic kidney (293) cells and in Ad40 Dugan plaques observed with Ad5 E1-expressing human retinoblastic cells. For the purpose of generating a single wild-type Ad40 clone, the entire Ad40 DNA was cloned into a plasmid by homologous recombination. A pure Ad40 was successfully generated by plasmid transfection and subsequently amplified with Ad5 E4orf6-inducible 293 (2V6.11) cells. 2V6.11 is an apposite cell line for effective Ad40 amplification and for future vector construction because Ad40 genetic integrity was maintained with this Ad5 E1 and E4orf6 trans-complementing cell line.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20490608      PMCID: PMC4569093          DOI: 10.1007/s00705-010-0683-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  38 in total

1.  Expression of the adenovirus E4 34k oncoprotein inhibits repair of double strand breaks in the cellular genome of a 293-based inducible cell line.

Authors:  Elham S Mohammadi; Elizabeth A Ketner; David C Johns; Gary Ketner
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

2.  Chronic intestinal infection due to subgenus F type 40 adenovirus in a patient with AIDS.

Authors:  D Dionisio; S Arista; E Vizzi; L I Manneschi; S Di Lollo; M Trotta; G Sterrantino; S Mininni; F Leoncini
Journal:  Scand J Infect Dis       Date:  1997

Review 3.  Enterically infecting viruses: pathogenicity, transmission and significance for food and waterborne infection.

Authors:  M J Carter
Journal:  J Appl Microbiol       Date:  2005       Impact factor: 3.772

4.  Ecdysone-inducible gene expression in mammalian cells and transgenic mice.

Authors:  D No; T P Yao; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex.

Authors:  Travis H Stracker; Christian T Carson; Matthew D Weitzman
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

6.  Cell type specific regulation of expression from the Ad40 E1b promoter in recombinant Ad5/Ad40 viruses.

Authors:  A Bailey; R Ullah; V Mautner
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

7.  Neutralizing antibodies against 33 human adenoviruses in normal children in Rome.

Authors:  E D'Ambrosio; N Del Grosso; A Chicca; M Midulla
Journal:  J Hyg (Lond)       Date:  1982-08

8.  Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children.

Authors:  I Uhnoo; G Wadell; L Svensson; M E Johansson
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

9.  A block in release of progeny virus and a high particle-to-infectious unit ratio contribute to poor growth of enteric adenovirus types 40 and 41 in cell culture.

Authors:  M Brown; H L Wilson-Friesen; F Doane
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Unusual splice sites in the E1A-E1B cotranscripts synthesized in adenovirus type 40-infected A549 cells.

Authors:  S Ishida; Y Fujinaga; K Fujinaga; N Sakamoto; S Hashimoto
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more
  3 in total

1.  Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer.

Authors:  Satoshi Yamasaki; Yoshiaki Miura; Julia Davydova; Selwyn M Vickers; Masato Yamamoto
Journal:  Int J Cancer       Date:  2012-12-21       Impact factor: 7.396

2.  A single intraduodenal administration of human adenovirus 40 vaccine effectively prevents anaphylactic shock.

Authors:  Satoshi Yamasaki; Yoshiaki Miura; Julia Davydova; Selwyn M Vickers; Masato Yamamoto
Journal:  Clin Vaccine Immunol       Date:  2013-07-24

3.  Species D human adenovirus type 9 exhibits better virus-spread ability for antitumor efficacy among alternative serotypes.

Authors:  Junji Uchino; David T Curiel; Hideyo Ugai
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.